Over 100 taken ill after consuming temple prasada'

Bengaluru, Mar 10: A 75-year-old man who arrived in Kalaburagi from Saudi Arabia on February 29 has been admitted to the isolation ward at Gulbarga Institute of Medical Sciences (GIMS) after he showed symptoms of coronavirus. 

His throat swab has been sent to the laboratory of Bengaluru’s Victoria Hospital. The district Health and Family Welfare Department is waiting for the report. 

The aged man who arrived from Saudi Arabia on February 28, was admitted to a private hospital on March 5 following fever and cough. As he showed the symptoms similar to coronavirus, the health of his family members has also been examined by the doctors and a close watch on them is being kept.

Recently, first confirmed positive case was reported from Whitefield in Bengaluru. The state government had also declared holiday for all primary schools in Bengaluru.

Udupi, Jun 9: Karnataka Minister for Primary and Secondary School S Suresh Kumar on Tuesday ruled out the possibility of either postponing or cancelling SSLC exam in the State and it will start from June 25 as scheduled.

Replying to a question, the Minister said that Telangana and Tamil Nadu States might have cancelled the SSLC exam, but Karnataka will not follow them. "Will hold the examination from June 25 to July 4 by taking all care to protect the interests of the Children.

The SSLC exam was originally scheduled for March 27, but was postponed as lockdown was clamped following the spread of killer Coronavirus.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.